• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗焦虑药物的安全性和副作用评估。

Evaluation of the safety and side effects of antianxiety agents.

作者信息

Schnabel T

出版信息

Am J Med. 1987 May 22;82(5A):7-13. doi: 10.1016/0002-9343(87)90197-5.

DOI:10.1016/0002-9343(87)90197-5
PMID:2884874
Abstract

Historically, the use of anxiolytic drugs has been associated with a relatively high incidence of side effects, particularly those related to central nervous system depression and sedation. These side effects can impair the patient's ability to function and, thus, interfere with the full achievement of therapeutic goals. In this article, the evolution of anxiolytic drug therapy from the perspective of safety and side effects is reviewed. Moreover, data concerning the safety of buspirone--a novel, non-benzodiazepine anxiolytic that has been shown to provide anxiolytic efficacy comparable to that of the benzodiazepines, but with a significantly lower potential for central nervous system depressant effects, interactions with alcohol, dependence, and abuse--are discussed.

摘要

从历史上看,抗焦虑药物的使用一直与相对较高的副作用发生率相关,尤其是那些与中枢神经系统抑制和镇静有关的副作用。这些副作用会损害患者的功能能力,从而干扰治疗目标的完全实现。本文从安全性和副作用的角度回顾了抗焦虑药物治疗的演变。此外,还讨论了有关丁螺环酮安全性的数据,丁螺环酮是一种新型非苯二氮䓬类抗焦虑药物,已被证明具有与苯二氮䓬类药物相当的抗焦虑疗效,但具有中枢神经系统抑制作用、与酒精相互作用、成瘾和滥用的可能性显著更低。

相似文献

1
Evaluation of the safety and side effects of antianxiety agents.抗焦虑药物的安全性和副作用评估。
Am J Med. 1987 May 22;82(5A):7-13. doi: 10.1016/0002-9343(87)90197-5.
2
Alcohol and drug interactions with antianxiety medications.
Am J Med. 1987 May 22;82(5A):27-33. doi: 10.1016/0002-9343(87)90200-2.
3
Impact of anxiety therapy on patients' quality of life.
Am J Med. 1987 May 22;82(5A):14-9. doi: 10.1016/0002-9343(87)90198-7.
4
Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.盐酸丁螺环酮:一种独特的新型抗焦虑药。药代动力学、临床药理学、滥用可能性及临床疗效。
Pharmacotherapy. 1984 Nov-Dec;4(6):315-24. doi: 10.1002/j.1875-9114.1984.tb03385.x.
5
Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.丁螺环酮。作为一种抗焦虑药的药理特性及治疗效果的初步综述。
Drugs. 1986 Aug;32(2):114-29. doi: 10.2165/00003495-198632020-00002.
6
Buspirone, a novel nonbenzodiazepine anxiolytic.丁螺环酮,一种新型非苯二氮䓬类抗焦虑药。
Clin Pharm. 1984 Nov-Dec;3(6):600-7.
7
A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.丁螺环酮与安慰剂缓解苯二氮䓬类药物戒断症状的比较。
J Clin Psychopharmacol. 1987 Feb;7(1):11-5.
8
Buspirone: a new type of anxiolytic.丁螺环酮:一种新型抗焦虑药。
Drug Intell Clin Pharm. 1985 Sep;19(9):624-8. doi: 10.1177/106002808501900903.
9
"Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".丁螺环酮:一种新型非苯二氮䓬类抗焦虑药的临床综述
J Clin Psychiatry. 1982 Dec;43(12 Pt 2):109-16.
10
Clinical studies of buspirone.
Psychopathology. 1984;17 Suppl 3:61-8. doi: 10.1159/000284132.

引用本文的文献

1
Designing combinational herbal drugs based on target space analysis.基于靶标空间分析设计组合草药药物。
BMC Complement Med Ther. 2024 May 1;24(Suppl 1):179. doi: 10.1186/s12906-024-04455-9.
2
A risk-benefit assessment of buspirone in the treatment of anxiety disorders.丁螺环酮治疗焦虑症的风险效益评估。
Drug Saf. 1997 Feb;16(2):118-32. doi: 10.2165/00002018-199716020-00004.